This study investigated the link between sodium/glucose transporter 2 (SGLT2) inhibitors and diabetic ketoacidosis (DKA). They found an increased number of cases of DKA in people treated with SGLT2 inhibitors.

This study examined the use of glutamine and sitagliptin as a treatment for type 2 diabetes mellitus.

This study compared the effects of vildagliptin (Zomelis) and glimepiride (Amaryl) on the rise and fall of blood glucose levels (glucose fluctuations) in patients with type 2 diabetes mellitus (T2DM). 

This study evaluated the effectiveness of insulin glargine 100U/ml (iGlar; Lantus) and lixisenatide (Lixi; Lyxumia) combined (iGlarLixi; Soliqua) compared with each of the two drugs alone in patients with type 2 diabetes (T2D) that was uncontrolled with 2 anti-diabetic oral drugs. The data showed that iGlarLixi resulted in better glucose control compared to iGlar or Lixi, and did not cause abnormally low blood glucose (hypoglycemia).

This study investigated the interaction of blood sugar, blood pressure and cholesterol management with physical and mental health in patients with type 2 diabetes. 

This study examined whether diabetes is associated with an earlier menopause.

This study examined whether mirogabalin is safe and effective in diabetics with peripheral neuropathy.

This study investigated the combined effect of vitamin D and calcium on the levels of sugar and fat in the blood of type 2 diabetes patients deficient in vitamin D.

This trial investigated the relationship between weight loss, lower blood glucose (sugar) levels and lower blood pressure in type 2 diabetics treated with canagliflozin.

This study examined whether having a good level of cardiorespiratory fitness is related to good blood sugar level control.